Avitcid

Quick links to important sections

Avitcid

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Avitcid

Quick Facts

Property Description
Active ingredient Tretinoin (All-Trans-Retinoic Acid)
Form Emulsion Cream (Topical)
Pharmacological class Topical Retinoid
Common Use Acne Vulgaris, Photodamage
Manufacturer Orion Oyj (Orion Pharma)

Avitcid: Defining its Identity and Pharmacological Class

Avitcid is a specialized, prescription-only topical medication. Its active ingredient is Tretinoin, which classifies it as a Topical Retinoid. Retinoids are a widely recognized class of compounds structurally related to Vitamin A, known for their influence on skin cell renewal and growth.

As a retinoid, Avitcid is designed to act directly on the skin's surface. Its primary goal is to normalize cell growth and differentiation, making it a foundation treatment for certain skin conditions where cell turnover is abnormal.


Origin and Composition

Avitcid contains Tretinoin, a synthetic metabolite of Vitamin A. The medication is delivered in an emulsion cream base, which is often considered a differentiating factor from alcohol-based gels. The cream formulation is intended to provide a potentially less irritating vehicle for the powerful active ingredient, a key factor in improving patient tolerance during initial use.

This specific composition and form are crucial because the vehicle determines how effectively the Tretinoin reaches the targeted skin layers.


General Therapeutic Purpose

The general therapeutic purpose of Avitcid is to regulate and normalize the processes of keratinization (skin cell production). By regulating these fundamental cellular functions, the medication helps to unclog pores and reduce the formation of new acne lesions. Tretinoin also helps to improve the appearance of chronically sun-damaged skin by supporting the regeneration of damaged skin layers.

What this means for the patient: The medicine offers a powerful, targeted method for managing persistent skin issues by working at a fundamental cellular level.

Regulatory References

  1. Tretinoin Topical Drug Information

What side effects are possible with Avitcid?

Possible Side Effects and Safety Information: Avitcid

The safety profile of Avitcid (Tretinoin topical) is primarily characterized by local cutaneous reactions classified as common in regulatory documents. These expected adverse reactions frequently involve the skin and application site, encompassing erythema (redness), peeling, dryness, a burning sensation, and pruritus (itching). Less common reported effects include pharyngitis and temporary changes in skin color (hyperpigmentation or hypopigmentation).


Safety Classifications and Patterns

Official labeling documents a specific time-related pattern for these effects. An apparent initial worsening of inflammatory lesions may occur during the early weeks of treatment. Furthermore, local irritation symptoms typically peak during the initial two weeks of therapy and gradually decrease thereafter. While rare, the potential for severe hypersensitivity reactions, such as anaphylaxis or angioedema, is documented as a serious safety concern.


Population-Specific Constraints

Explicit safety constraints exist for certain populations. The medicine is contraindicated in pregnant women due to the known risks associated with the drug class. Caution is advised for women who are breastfeeding. Additionally, the label notes that Avitcid may cause severe irritation on eczematous skin, necessitating its use with utmost caution in this patient group.


Restrictions and Environmental Factors

The medication is officially noted to increase sensitivity to ultraviolet light (photosensitivity). Therefore, minimizing unprotected exposure to sunlight and sunlamps is a mandated safety restriction. Regulatory documents also specify that severe wind or cold may cause irritation to the treated skin, defining environmental factors that impact its safety profile. This framework establishes the necessary boundaries for safe use.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Avitcid (Tretinoin Topical) distinguishes between two principal overdose scenarios based on the route of exposure.

1. Overdose from Excessive Topical Application

Over-application of the emulsion cream may lead to severe local irritation. Documented manifestations include marked redness, peeling, severe burning or stinging, or the development of swelling, blistering, or crusting of the treated skin. When this severe local irritation occurs, regulatory guidance directs that the frequency or amount of application be reduced, or that use be temporarily discontinued until the reactions subside.

2. Overdose from Accidental Oral Ingestion

Accidental oral ingestion poses a risk of systemic toxicity with manifestations similar to those associated with excessive oral intake of Vitamin A (Hypervitaminosis A). Systemic signs may include severe headache, stomach pain, flushing, dizziness, and loss of coordination.

Regulator-Mandated Emergency Actions

Immediate emergency services (911) must be contacted if accidental ingestion leads to life-threatening manifestations such as collapse, a seizure, trouble breathing, or if the person cannot be awakened. For guidance on all overdose situations, contact with the Poison Control Helpline is advised. No specific antidote for Tretinoin overdose is documented in official labeling; therefore, management is focused on providing symptomatic and supportive treatment.

Therapeutic Uses of Avitcid

What Avitcid Treats: Main Uses and Benefits

Avitcid is generally used for managing chronic skin conditions characterized by periods of heightened symptoms, and is relevant within therapeutic domains such as Acne Management and the mitigation of Photodamage. It is generally used for managing acne vulgaris and may assist with symptoms associated with sun damage, such as fine wrinkles, spotty discoloration, and rough feeling skin.

The key conditions it addresses include Acne Vulgaris (used for managing lesions and breakouts) and Photodamage (relevant for easing texture and pigmentation issues), alongside its application in managing Post-Inflammatory Hyperpigmentation (PIH). The medication supports symptomatic relief for persistent skin issues, contributing to improved day-to-day comfort during symptomatic periods.

It is commonly applied in clinical settings that involve recurrent breakouts and may assist with the management of the overall symptom load of persistent acne. For those concerned with sun-induced changes, it is relevant for easing symptoms related to uneven skin texture and discoloration, which provides supportive relief when symptoms interfere with routine activities.


Quick Fact: Relief for Acne and Pigmentary Symptoms

Domain Symptom Cluster Managed Key Benefit
Acne Management Blackheads, whiteheads, inflammatory blemishes. Supports control of persistent breakouts.
Photoaging / PIH Fine wrinkles, dark spots, rough texture. Contributes to a more even and smoother skin appearance.

Regulatory References

  1. NIH MedlinePlus overview of Tretinoin Topical

Eligibility and Restrictions for Use

Who Can and Cannot Use Avitcid?

Avitcid is a prescription topical retinoid whose use is defined by strict regulatory population eligibility rules and contraindications.


Populations with Absolute Contraindications

Avitcid is contraindicated and must not be used by patients with a known hypersensitivity to Tretinoin or any excipient in the cream formulation. Use is also contraindicated during pregnancy, as regulatory bodies note the established risks associated with retinoids.


Age and Conditional Use Restrictions

Eligibility is primarily established for adults and adolescents 12 years of age and older. The safety and efficacy are not established for use in children younger than 12 years or in older adults (65 years and older). Use is not recommended for individuals who are breastfeeding.

Conditional use applies to the application site: the medicine must not be used on severely sunburned skin until full recovery. It must be used with utmost caution, or avoided, on areas affected by severe eczema or pre-existing local irritation. Due to minimal systemic absorption, official labeling generally does not specify restrictions based on moderate renal or hepatic impairment.

What should I know about interactions with other medicines?

Avitcid, which is a formulation of tretinoin, can interact with various other medicines and products, which may alter its effectiveness or increase the risk of side effects. It is crucial to inform your healthcare provider about all prescription, over-the-counter, and herbal products you are currently using.

Topical Products to Avoid

The simultaneous use of topical preparations that cause skin irritation or significant drying should be avoided, as this may intensify the skin reaction to Avitcid. Examples include products containing:

  • Sulfur, resorcinol, or salicylic acid
  • Benzoyl peroxide
  • Astringents, peeling agents, or abrasive soaps and cleansers
  • High concentrations of alcohol

Additionally, extreme caution is advised with wax depilatory preparations on the treated areas due to the risk of severe skin stripping.

Potential Drug Interactions

While systemic absorption of topically applied Avitcid is generally low, caution is warranted with certain oral medications due to potential systemic effects, including:

Drug Class Potential Interaction Clinical Effect
Tetracyclines (e.g., doxycycline, minocycline) Increased risk of pseudotumor cerebri (benign intracranial hypertension) Increased pressure around the brain
Other Retinoids (e.g., isotretinoin, alitretinoin) Increased risk of dose-related adverse effects Synergistic toxicity

Patients should avoid excessive exposure to sunlight, sunlamps, or tanning beds, as Avitcid can increase sensitivity to ultraviolet light, leading to a severe sunburn-like reaction.

Mechanism of Action

How Avitcid Works: Mechanistic Overview

Avitcid is a synthetic retinoid analog that functions at the molecular level to regulate gene expression and alter cellular processes.


Modulating Gene Transcription via Nuclear Receptors

Avitcid primarily acts as a nuclear receptor ligand by engaging the retinoic acid receptors (RARs) and retinoid X receptors (RXRs) within the cell nucleus. Binding to these nuclear transcription factors modulates the expression of genes involved in cellular growth and differentiation.


Altering Epithelial Cell Differentiation Pathways

The drug modifies molecular steps that govern the differentiation and proliferation of keratinocytes in the epithelium. This action alters the expression of genes that regulate keratinocyte maturation, resulting in the altered expression of genes governing cellular phenotype.


Modulating Immunological Mediator Expression

Avitcid initiates sequences that modulate the expression of transcripts encoding various inflammatory mediators. This modulation influences feedback regulation within signaling pathways, resulting in altered systemic physiological outcomes.

Dosage and Administration Information

How Avitcid is Used: Official Administration Guidelines

Avitcid, a topical formulation containing Tretinoin, is administered solely via the cutaneous (topical) route as directed. The product is not intended for oral, ocular, or mucosal use.


Official Usage Protocol

The standard regimen dictates a once-daily application typically performed in the evening, just before bedtime. The application process requires the skin to be gently cleansed, patted dry, and then allowed to dry completely for 20 to 30 minutes before the cream is applied.

The dosage involves applying a thin layer of the medication to the entire affected area, not just individual lesions. The amount recommended for the entire facial area is generally described as a half-inch or less of cream, or a small pea-sized amount. It is explicitly stated that using an excessive amount will not accelerate results and may lead to increased local irritation. The cream must be kept away from sensitive areas, including the eyes, mouth, angles of the nose, and mucous membranes.


Treatment Duration and Adjustments

Therapy with topical Tretinoin requires a long-term approach; sustained clinical benefit for conditions like acne vulgaris is generally not observed until after six to eight weeks of continuous use. If significant local irritation occurs, standard guidance directs that the application frequency be temporarily reduced (e.g., to every other day) or discontinued until symptoms resolve, after which the regimen can be resumed.

In the event of a missed evening dose, the patient should apply the next scheduled dose at the usual time and must not double the application to compensate. The medication is indicated for use in pediatric patients 12 years of age and older for acne management, although safety for use in younger children is not established.

Recent Clinical Evidence

Research evidence / Overview of Studies for Avitcid (Tretinoin)


Evidence for studies of Acne Vulgaris

Research into the active ingredient of Avitcid, Tretinoin, is primarily based upon studies examining its application for Acne Vulgaris. The core evidence base is built upon short-term, randomized controlled trials (RCTs). In these studies, Tretinoin was evaluated against an inactive vehicle cream to observe measured outcomes over defined time intervals. Researchers primarily examined changes in the number of acne lesions (both blackheads/whiteheads and inflammatory pimples) and monitored patient-reported outcomes describing perceived discomfort. These studies included populations of adolescents and adults with mild-to-moderate facial acne.

In these research scenarios, trials described patterns where total acne lesion counts were measured and observed to evolve compared to the vehicle cream. Studies reported measurements of symptom changes in the observed populations, with findings typically described over the typical 8-to-12-week evaluation windows. The overall findings help contextualize how patients reported their experience when Tretinoin was used for these conditions, which are characterized by fluctuating or episodic manifestations.

However, certain research limitations exist. The results apply only to the populations studied, and evidence is limited for very long-term outcomes (beyond 40 weeks). Furthermore, the evidence quality varies across studies due to differences in the concentration and type of Tretinoin formula used in the trials.


Evidence for studies of Photodamage and Fine Wrinkles

Avitcid's active ingredient was also evaluated in studies examining outcomes related to symptoms associated with photodamage, which is marked by functional limitations such as fine wrinkles and texture issues. Research in this area involved long-term, randomized controlled trials (RCTs), with some studies lasting up to two years. Study outcomes examined included the severity of fine and coarse wrinkles, the appearance of mottled hyperpigmentation (dark spots), and overall skin roughness.

Findings from these long-term studies describe patterns observed in the research related to these characteristics. Trials reported measurements of skin texture that were observed to change during the study period. Research also highlights changes measured during the study period for discoloration and roughness.

Despite these findings, long-term effects are not fully established, particularly for effects that may persist beyond two years. The results apply only to the populations studied, and comparative evidence is lacking against newer topical treatments designed for photoaging.


What Research Gaps Remain Uncertain

While a large volume of research is available, evidence highlights what is known—and what is still uncertain. Comparative evidence is lacking between Tretinoin and the newest topical treatments for both acne and photoaging. The follow-up durations were limited in many acne studies, restricting insight into the durability of observed outcomes. Finally, results apply only to the populations studied, and the evidence quality varies across studies due to differences in formulation, making it challenging to synthesize a clear, consistent picture across all clinical presentations. Findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Tretinoin Microsphere Gel in Facial Acne Vulgaris: A Meta-Analysis
  2. Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color

Frequently Asked Questions (FAQ)

Common questions about Avitcid (FAQ)


Q: Can Avitcid be used for reducing the appearance of fine wrinkles, as well as acne?

The active ingredient in Avitcid is formally indicated for the topical treatment of acne vulgaris. The active ingredient is also indicated for the topical treatment in some formulations to address signs of sun damage, such as fine wrinkles, dark spots, or rough skin.


Q: What are the limitations of Avitcid's effectiveness mentioned in research?

Studies and official product information indicate that sustained clinical benefits typically require six to eight weeks or more of continuous use before they are observed. Furthermore, patients may experience an initial, temporary worsening of inflammatory lesions in the early weeks of therapy, and official guidance describes adjusting the application frequency if irritation is significant.


Q: Can Avitcid affect the skin's color, causing temporary lightening or darkening?

According to official adverse reactions information, temporary changes in skin color have been reported with the use of the active ingredient. These changes may include both lightening (hypopigmentation) and darkening (hyperpigmentation) of the treated area.


Q: What is the general advice for using moisturizers alongside Avitcid application?

Non-medicated moisturizers can be used to help manage the dryness and irritation that often occur during treatment. Some official guidance describes using non-irritating moisturizers during the day to help prevent potentially diluting the medication’s effect when applied near the nightly dose.


Q: Does Avitcid interfere with the effectiveness of hormonal birth control pills?

Systemic absorption of the active ingredient through the skin following topical application is generally reported as low. The official labeling for topical Avitcid does not typically list interference with hormonal birth control pills as an interaction.


Q: Are there age restrictions for who can use Avitcid?

The medication is generally indicated for use in adolescents 12 years of age and older for acne treatment. However, official information states that safety and efficacy have not been established for children younger than 12 years or for older adults (65 years and older).


Q: Are there different brand names for the active chemical in Avitcid?

Yes, the active chemical in Avitcid is Tretinoin, which is the generic name. Tretinoin is used in various topical formulations, and it is available under several different brand names.


Q: Why are there different strengths (e.g., 0.025% vs 0.05%) of Avitcid available?

The availability of different strengths is intended to allow for individualized treatment. The dosage choice is based on the intended treatment goal and skin tolerability, as higher concentrations can increase the risk of local skin irritation.


Q: Are there any common non-skin related side effects mentioned for Avitcid?

While the most frequently reported side effects are local skin reactions, some clinical trial data for topical tretinoin have reported sore throat, known as pharyngitis, as a less common, non-skin related effect.


Q: Are there signs that I might be allergic to Avitcid?

Signs of a potential severe reaction, which are rare, may include severe itching, hives, or swelling of the face, mouth, or throat. Difficulty breathing is also noted as a serious sign that requires immediate attention.


Q: Is Avitcid effective for treating post-acne dark spots (hyperpigmentation)?

Official information notes that the active ingredient in Avitcid is indicated in some formulations to treat dark spots, specifically those caused by chronic sun damage.


Q: What happens if I use abrasive scrubs or peels while on Avitcid?

Official warnings state that combining Avitcid with abrasive products, chemical peels, or strong astringents may intensify local skin irritation. This can potentially lead to excessive redness, dryness, or severe peeling in the treated areas.


Q: Is the active ingredient in Avitcid the same as the one used in some cancer treatments?

Yes, the active ingredient, Tretinoin, is the same chemical name used in both topical acne and photoaging medications and in certain oral medications. The oral form is used to treat a specific type of blood cancer called Acute Promyelocytic Leukemia.


Q: Why is the Avitcid gel formulation sometimes described as flammable?

Gel formulations of the active ingredient typically contain an alcohol-based vehicle. Official warnings state that this vehicle is flammable and advises avoiding exposure to fire, flame, or smoking during the application process.


Q: What are the components (inactive ingredients) found in the Avitcid formulation?

The complete list of inactive ingredients, or excipients, used in the specific cream or gel formulation is detailed in the product’s official prescribing information or package insert.


Q: What are the signs of a rare but serious adverse reaction to Avitcid?

Signs of a rare but serious adverse reaction may include severe itching, hives, swelling of the face, tongue, or throat, or difficulty breathing. These reactions are associated with severe hypersensitivity.


Q: How quickly does the active ingredient in Avitcid absorb into the body?

Official pharmacokinetic data indicates that systemic absorption of the active ingredient through the skin is generally low following topical application.


Q: Can Avitcid be used on other areas of the body, not just the face?

The medication is formally indicated for the topical treatment of acne vulgaris. Safety and effectiveness for application to other areas of the body or other types of lesions have not been established through regulatory documentation.


Q: What evidence is available about the long-term safety of continuous Avitcid use?

Clinical trial evidence generally covers specific timeframes, with studies sometimes lasting up to two years. Data regarding the long-term safety profile of the medication beyond the duration of these specific studies is considered limited.

How should Avitcid be stored and disposed of?

How to Store and Dispose of Avitcid (Tretinoin Cream)

Official regulatory documents specify strict conditions to maintain the stability and safety of Avitcid cream.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 to 25 C (68 to 77 F).
Protection Protect from freezing and excessive heat; store away from moisture and direct light.
Container Keep the tube tightly closed when not in use.
Child Safety Keep this and all medications out of the reach of children.

Disposal

Do not keep outdated or unused medicine. The official guidance states to ask your healthcare professional how you should dispose of any unused Avitcid, ensuring compliance with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Avitcid found in:

A-Z Index: